Literature DB >> 29594060

Prevalence of Radiological Signs of Dysthyroid Optic Neuropathy in Magnetic Resonance Imaging in Patients with Active, Moderate-to-Severe, and Very Severe Graves Orbitopathy.

Beata Rutkowska-Hinc1, Edyta Maj2, Anna Jabłońska3, Justyna Milczarek-Banach1, Tomasz Bednarczuk1, Piotr Miśkiewicz1.   

Abstract

BACKGROUND: Differentiating between dysthyroid optic neuropathy (DON), which requires urgent therapy to prevent blindness, and moderate-to-severe Graves orbitopathy (GO) remains challenging. There is no pathognomonic feature of DON in either ophthalmological or radiological examinations.
OBJECTIVES: Our aim was to investigate the prevalence of radiological signs of DON in magnetic resonance imaging (MRI) in patients with moderate-to-severe and very severe GO.
METHODS: Two researchers reassessed MRI scans of 23 consecutive patients (46 eyes) with active, moderate-to-severe GO and 14 patients (23 eyes) with very severe GO. Typical signs of DON in MRI include apical crowding and optic nerve stretching. These were evaluated in the eyes of both groups of patients. Lack of cerebrospinal fluid in the optic nerve sheath as well as muscle index values were also studied. These clinical evaluations and laboratory results were then compared between groups.
RESULTS: At least one of the typical radiological features of DON was found in 22 (96%) and 16 (35%) eyes with very severe and moderate-to-severe GO, respectively. Each occurred statistically more often in patients with very severe GO. There were no ophthalmological signs of very severe GO observed in the group of patients with moderate-to-severe GO during the study or its subsequent follow-up (234 weeks).
CONCLUSIONS: MRI is a useful tool in evaluating very severe GO. However, features typical for DON are also found in up to 35% of eyes in patients with active, moderate-to-severe GO. Therefore, ophthalmological evaluation seems to be most important in the recognition of very severe GO.

Entities:  

Keywords:  Dysthyroid optic neuropathy; Graves disease; Graves orbitopathy; Magnetic resonance imaging; Very severe Graves orbitopathy

Year:  2018        PMID: 29594060      PMCID: PMC5869563          DOI: 10.1159/000486828

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  25 in total

1.  Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?

Authors:  Colin M Dayan; Margaret R Dayan
Journal:  Br J Ophthalmol       Date:  2007-04       Impact factor: 4.638

Review 2.  [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging].

Authors:  Yuji Hiromatsu; Hiroyuki Eguchi; Junichi Tani
Journal:  Nihon Rinsho       Date:  2012-11

3.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

4.  Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.

Authors:  Jwu Jin Khong; Sue Finch; Chamika De Silva; Stacey Rylander; Jamie E Craig; Dinesh Selva; Peter R Ebeling
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

5.  Graves orbitopathy: correlation of CT and clinical findings.

Authors:  R A Nugent; R I Belkin; J M Neigel; J Rootman; W D Robertson; J Spinelli; D A Graeb
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

6.  Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.

Authors:  David McKeag; Carol Lane; John H Lazarus; Lelio Baldeschi; Kostas Boboridis; A Jane Dickinson; A Iain Hullo; George Kahaly; Gerry Krassas; Claudio Marcocci; Michele Marinò; Maarten P Mourits; Marco Nardi; Christopher Neoh; Jacques Orgiazzi; Petros Perros; Aldo Pinchera; Susanne Pitz; Mark F Prummel; Maria S Sartini; Wilmar M Wiersinga
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

7.  Use of high-resolution MRI of the optic nerve in Graves' ophthalmopathy.

Authors:  N I Dodds; A W Atcha; D Birchall; A Jackson
Journal:  Br J Radiol       Date:  2009-01-05       Impact factor: 3.039

8.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

9.  Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.

Authors:  Allan C Pieroni Gonçalves; Lucas Nunes Silva; Eloísa M M S Gebrim; Suzana Matayoshi; Mário Luiz Ribeiro Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

10.  Diagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography.

Authors:  Mário L R Monteiro; Allan C P Gonçalves; Carla T M Silva; Janete P Moura; Carolina S Ribeiro; Eloisa M M S Gebrim
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more
  10 in total

1.  Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.

Authors:  Sandra Rezar-Dreindl; Andrea Papp; Arnulf Baumann; Thomas Neumayer; Katharina Eibenberger; Eva Stifter; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-22       Impact factor: 3.535

2.  Radiomics analysis of the optic nerve for detecting dysthyroid optic neuropathy, based on water-fat imaging.

Authors:  Hongyu Wu; Ban Luo; Yali Zhao; Gang Yuan; Qiuxia Wang; Ping Liu; Linhan Zhai; Wenzhi Lv; Jing Zhang
Journal:  Insights Imaging       Date:  2022-09-24

3.  Multi-Parametric Diffusion Tensor Imaging of The Optic Nerve for Detection of Dysthyroid Optic Neuropathy in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Ping Liu; Ban Luo; Lin-Han Zhai; Hong-Yu Wu; Qiu-Xia Wang; Gang Yuan; Gui-Hua Jiang; Lang Chen; Jing Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

4.  RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy.

Authors:  Vinita Gupta; Sucharita Das; Shalini Mohan; Udit Chauhan
Journal:  J Family Med Prim Care       Date:  2022-01-31

5.  Altered peripapillary vessel density and nerve fiber layer thickness in thyroid-associated ophthalmopathy using optical coherence tomography angiography.

Authors:  Huan Jian; Yujiao Wang; Luyu Ou; Weimin He
Journal:  Int Ophthalmol       Date:  2021-10-12       Impact factor: 2.031

6.  Diagnostic Ability of Barrett's Index and Presence of Intracranial Fat Prolapse in Dysthyroid Optic Neuropathy.

Authors:  Parinee Kemchoknatee; Alisa Chenkhumwongse; Thanchanok Dheeradilok; Thansit Srisombut
Journal:  Clin Ophthalmol       Date:  2022-08-12

7.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

8.  Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.

Authors:  Zhihong Deng; Lu Chen; Jia Tan; Sha Wang; Dan Liu; Jinwei Wang; Chengzhi Jiang; Jie Yang; Bei Xu
Journal:  Dis Markers       Date:  2021-05-18       Impact factor: 3.434

9.  Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?

Authors:  Lakshmi B Ramamurthy; Viji Rangarajan; Neha Srirao; Bindu Malini; Renu Bansal; Kavitha Yuvarajan
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

10.  Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.

Authors:  Connie M Sears; Yao Wang; Lucy A Bailey; Roger Turbin; Prem S Subramanian; Raymond Douglas; Kimberly Cockerham; Andrea L Kossler
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.